What is the dosing frequency of Levetiracetam for a 65kg adult with status epilepticus, bid or qid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levetiracetam Dosing Frequency

Levetiracetam is dosed twice daily (BID), not four times daily (QID), for all indications including status epilepticus. 1, 2, 3

Standard Dosing Frequency Across All Indications

The FDA-approved dosing for levetiracetam is consistently every 12 hours (BID) regardless of indication 3:

  • Status epilepticus loading dose: 30 mg/kg IV over 5 minutes, followed by maintenance dosing every 12 hours 1, 2
  • Maintenance after status epilepticus resolution:
    • Convulsive SE: 30 mg/kg IV every 12 hours (maximum 1,500 mg per dose) 1, 2
    • Non-convulsive SE: 15 mg/kg IV every 12 hours (maximum 1,500 mg per dose) 1, 2
  • Chronic epilepsy management: 500-1,500 mg every 12 hours for adults 3

Specific Dosing for Status Epilepticus in a 65kg Adult

For your 65kg patient with status epilepticus, the dosing would be 2:

  1. Loading dose: 1,950 mg IV (30 mg/kg × 65 kg) over 5 minutes
  2. Maintenance: 1,500 mg IV every 12 hours (maximum dose per the guidelines)

Why BID and Never QID

The pharmacokinetic profile of levetiracetam supports twice-daily dosing 4:

  • Elimination half-life: 8.7-10.1 hours in critically ill patients 4
  • Volume of distribution: 0.65 L/kg 4
  • This half-life allows for stable therapeutic levels with 12-hour dosing intervals

All major guidelines and the FDA label consistently specify BID dosing—there is no clinical scenario where QID dosing is recommended or necessary. 1, 2, 3

Renal Dosing Adjustments (Still BID)

Even in renal impairment, the frequency remains every 12 hours, with dose reductions 3:

  • CrCl 50-80 mL/min: 500-1,000 mg every 12 hours
  • CrCl 30-50 mL/min: 250-750 mg every 12 hours
  • CrCl <30 mL/min: 250-500 mg every 12 hours
  • ESRD on dialysis: 500-1,000 mg every 24 hours (with supplemental dose post-dialysis)

The only exception where dosing extends beyond 12 hours is in end-stage renal disease requiring dialysis, where it becomes once daily 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.